The recently published research showed that the company’s COBLATION Intracapsular Tonsillectomy technique showed better postoperative outcomes in patients, compared to total tonsillectomy techniques
COBLATION Technology shows superior results. (Credit: JAFAR AHMED on Unsplash)
UK-based medical technology company Smith+Nephew has announced positive results for its COBLATION Intracapsular Tonsillectomy (CIT) technique from new scientific research.
The recently published research showed that the company’s CIT technique showed better postoperative outcomes in patients, compared to total tonsillectomy techniques.
It is a systematic literature review that evaluated 17 clinical studies on 6,501 paediatric and adult patients who received either CIT or total tonsillectomy over a period of 20 years.
CIT or total tonsillectomy is used for the treatment of recurrent tonsillitis or obstructive sleep apnoea.
Traditional total tonsillectomy involves the removal of all the tonsil tissue and its underlying capsule, which exposes the muscle bed and the blood vessels that lie within the muscle.
Unlike the traditional method, CIT involves the removal of the entire, or a part of the tonsil tissue, while protecting the underlying capsule that remains intact.
Leveraging its COBLATION Technology, Smith+Nephew delivers CIT that creates a controlled, stable plasma field at a low relative temperature.
CIT enables minimal thermal damage and precise removal of surrounding soft tissue.
According to the research results, the patients who received CIT experienced several improved outcomes, compared to total tonsillectomy.
CIT also resulted in fewer post-operative complications, where 64% of patients are less likely to experience post-tonsillectomy haemorrhage (PTH).
In addition, the technique also enabled a reduction in pain severity, duration and post-operative analgesia use, and a faster return to normal activity and diet.
Smith+Nephew Global ENT vice president and general manager Meghan Mavity said: “We are thrilled to share the findings of this meta-analysis.
“The impact that this technology and technique have on patient outcomes is clear and reflects our commitment to ensuring surgeons have the tools they need to make a significant improvement in patients’ lives.”
Earlier this month, Smith+Nephew launched UltraTRAC QUAD ACL Reconstruction Technique to expand its ability to address surgeon graft preference and provide an innovative procedural solution.